Antiangiogenic drug to treat cancer, arthritis and retinopathy

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530326, 530327, 530328, 514 13, 514 14, 514 15, 514 16, A61K 3800

Patent

active

059325453

ABSTRACT:
Peptides having the formula:

REFERENCES:
Journal of Peptide Research, vol. 50, No. 3 (Sep. 1997), pp. 210-221, Guo et al., "Antiproliferative and Antitumor Activities of D-Reverse Peptides Derived from the Second Type-1 Repeat of Thrombospondin-1".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antiangiogenic drug to treat cancer, arthritis and retinopathy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiangiogenic drug to treat cancer, arthritis and retinopathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiangiogenic drug to treat cancer, arthritis and retinopathy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-849452

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.